Polypharmacy and clinical outcomes

descriptionPublicationkeyboard_double_arrow_right Article 10 Aug 2015 English Publisher:CMA Joule Inc.Journal:Canadian Medical Association Journal, volume 187, pages 827.1-827 (issn: 0820-3946, eissn: 1488-2329,

Copyright policy )

Authors: Hsiu-Nien, Shen;

doi: 10.1503/cmaj.1150048

pmid: 26261270

pmc: PMC4527909

Polypharmacy and clinical outcomes

- Summary
- Subjects
- Metrics

Abstract

I read with interest the article by Lu and colleagues[1][1] which shows that quality indicators of pharmacotherapy are associated with increased odds of admission to hospital, but reduced odds of death. However, some problems in the analysis may explain the results. Specifically, based on Tables 1

Related Organizations

Chi Mei Medical Center
Taiwan

Keywords

Male, Drug Utilization Review, Outcome and Process Assessment, Health Care, Patient Admission, Polypharmacy, Humans, Hypnotics and Sedatives, Female, Inappropriate Prescribing, Cholinergic Antagonists

Impact byBIP!

	selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	5
	popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.	Average
	influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	Top 10%
	impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.	Average